These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31235559)

  • 1. Treatment of Multidrug-Resistant Vancomycin-Resistant Enterococcus faecium Hardware-Associated Vertebral Osteomyelitis with Oritavancin plus Ampicillin.
    Dahesh S; Wong B; Nizet V; Sakoulas G; Tran TT; Aitken SL
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31235559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Oritavancin Dosing Strategies against Vancomycin-Resistant Enterococcus faecium Isolates with or without Reduced Susceptibility to Daptomycin in an
    Belley A; Arhin FF; Moeck G
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of oritavancin alone or in combination against vancomycin-susceptible and -resistant enterococci.
    Wu T; Meyer K; Harrington AT; Danziger LH; Wenzler E
    J Antimicrob Chemother; 2019 May; 74(5):1300-1305. PubMed ID: 30753495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
    Smith JR; Yim J; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial resistance profile of Enterococcus species isolated from intestinal tracts of hospitalized patients in Jimma, Ethiopia.
    Abamecha A; Wondafrash B; Abdissa A
    BMC Res Notes; 2015 Jun; 8():213. PubMed ID: 26036911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Pharmacodynamics of Single-Dose Oritavancin and Daily High-Dose Daptomycin Regimens against Vancomycin-Resistant Enterococcus faecium Isolates in an
    Belley A; Lalonde-Séguin D; Arhin FF; Moeck G
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced sensitivity of vancomycin/ampicillin broth enrichment for the detection of
    Heuvelmans M; Sturm PDJ; Rentenaar RJ
    Infect Dis (Lond); 2019; 51(11-12):874-877. PubMed ID: 31469338
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolonged linezolid use is associated with the development of linezolid-resistant Enterococcus faecium.
    Smith TT; Tamma PD; Do TB; Dzintars KE; Zhao Y; Cosgrove SE; Avdic E
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):161-163. PubMed ID: 29496381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vertebral osteomyelitis caused by vancomycin-resistant Enterococcus spp.: a case series.
    Russo A; Venditti M
    Int J Antimicrob Agents; 2021 Nov; 58(5):106432. PubMed ID: 34525403
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of oritavancin alone and in combination against vancomycin-susceptible and -resistant enterococci in an in-vivo Galleria mellonella survival model.
    Meyer KA; Deraedt MF; Harrington AT; Danziger LH; Wenzler E
    Int J Antimicrob Agents; 2019 Aug; 54(2):197-201. PubMed ID: 31034937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ampicillin for the treatment of complicated urinary tract infections caused by vancomycin-resistant Enterococcus spp (VRE): a single-center university hospital experience.
    Shah KJ; Cherabuddi K; Shultz J; Borgert S; Ramphal R; Klinker KP
    Int J Antimicrob Agents; 2018 Jan; 51(1):57-61. PubMed ID: 28666756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,2,4-Oxadiazole antimicrobials act synergistically with daptomycin and display rapid kill kinetics against MDR Enterococcus faecium.
    Carter GP; Harjani JR; Li L; Pitcher NP; Nong Y; Riley TV; Williamson DA; Stinear TP; Baell JB; Howden BP
    J Antimicrob Chemother; 2018 Jun; 73(6):1562-1569. PubMed ID: 29518208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of chloramphenicol alone and in combination with vancomycin, ampicillin, or RP 59500 (quinupristin/dalfopristin) against vancomycin-resistant enterococci.
    Messick CR; Pendland SL
    Diagn Microbiol Infect Dis; 1997 Nov; 29(3):203-5. PubMed ID: 9401814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oritavancin activity against vancomycin-susceptible and vancomycin-resistant Enterococci with molecularly characterized glycopeptide resistance genes recovered from bacteremic patients, 2009-2010.
    Mendes RE; Woosley LN; Farrell DJ; Sader HS; Jones RN
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1639-42. PubMed ID: 22183169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococci.
    Messick CR; Woodward J; Pendland SL
    Diagn Microbiol Infect Dis; 1998 Oct; 32(2):95-9. PubMed ID: 9823531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
    Hall Snyder A; Werth BJ; Barber KE; Sakoulas G; Rybak MJ
    J Antimicrob Chemother; 2014 Aug; 69(8):2148-54. PubMed ID: 24777900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of oritavancin against planktonic and biofilm states of vancomycin-susceptible and vancomycin-resistant enterococci.
    Yan Q; Karau MJ; Patel R
    Diagn Microbiol Infect Dis; 2018 Aug; 91(4):348-350. PubMed ID: 29678300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin-resistant Enterococcus faecium osteomyelitis: successful treatment with quinupristin-dalfopristin.
    Summers M; Misenhimer GR; Antony SJ
    South Med J; 2001 Mar; 94(3):353-5. PubMed ID: 11284529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftaroline Plus Ampicillin Against Gram-Positive Organisms: Results from E-Test Synergy Assays.
    D'Arezzo S; Mazzarelli A; Venditti C; Nisii C; Petrosillo N; De Giuli C; Vulcano A; Paglia MG; Bordi E; Di Caro A; Taglietti F
    Microb Drug Resist; 2017 Jun; 23(4):507-515. PubMed ID: 27526275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium.
    Till M; Wixson RL; Pertel PE
    Clin Infect Dis; 2002 May; 34(10):1412-4. PubMed ID: 11981739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.